Aventis Pharmaceuticals, Inc.
6 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| AB 103: Pharmaceuticals: marketing activities | Bills it lobbied on | Aventis Pharmaceuticals, Inc. named AB 103, “Pharmaceuticals: marketing activities”, in 2 lobbying reports. | 2 reports |
| AB 262: Pharmacies: physician prescribing data | Bills it lobbied on | Aventis Pharmaceuticals, Inc. named AB 262, “Pharmacies: physician prescribing data”, in 3 lobbying reports. | 3 reports |
| SB 1563: Pharmacy manufacturers: price regulation | Bills it lobbied on | Aventis Pharmaceuticals, Inc. named SB 1563, “Pharmacy manufacturers: price regulation”, in 1 lobbying report. | 1 report |
| SB 1333: Prescription drug reimbursement: pharmacy purchases from Canadian sources: Medi-Cal: AIDS Drug Assistance program | Bills it lobbied on | Aventis Pharmaceuticals, Inc. named SB 1333, “Prescription drug reimbursement: pharmacy purchases from Canadian sources: Medi-Cal: AIDS Drug Assistance program”, in 1 lobbying report. | 1 report |
| SB 306: University of California Pharmaceutical Drug Evaluation Commission | Bills it lobbied on | Aventis Pharmaceuticals, Inc. named SB 306, “University of California Pharmaceutical Drug Evaluation Commission”, in 1 lobbying report. | 1 report |
| Eloise Reyes | Lawmakers it funded or lobbied | Eloise Reyes leads 1 bill Aventis Pharmaceuticals, Inc. lobbied on. | Leads 1 of these bills |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…